M&A Deal Summary

Boston Scientific Acquires Neovasc - Biological Tissue Capabilities

On December 2, 2016, Boston Scientific acquired medical products company Neovasc - Biological Tissue Capabilities from Neovasc

Acquisition Highlights
  • This is Boston Scientific’s 28th transaction in the Medical Products sector.
  • This is Boston Scientific’s 2nd transaction in Canada.
  • This is Boston Scientific’s 2nd transaction in British Columbia.

M&A Deal Summary
Date 2016-12-02
Target Neovasc - Biological Tissue Capabilities
Sector Medical Products
Buyer(s) Boston Scientific
Sellers(s) Neovasc
Deal Type Divestiture

Target

Neovasc - Biological Tissue Capabilities

Richmond, British Columbia, Canada
Neovasc, Inc. - Biological Tissue Capabilities is a manufacturer of medical products in Canada.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 40 of 65
Sector (Medical Products) 28 of 49
Type (Divestiture) 8 of 11
State (British Columbia) 2 of 2
Country (Canada) 2 of 3
Year (2016) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-02 Neovasc

Richmond, British Columbia, Canada

Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Neovasc was founded in 2000 and is based in Richmond, British Columbia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-30 Symetis SA

Lausanne, Switzerland

Symetis SA is a developer of innovative, minimally invasive heart valve replacement devices. The company’s products, ACURATE TA™ and ACURATE neo™ and their delivery systems, based on proprietary design and delivery technologies, are marketed and sold in key markets in Europe and in other markets, and are well positioned to target the constantly growing TAVI market.

Buy $435M

Seller(S) 1

SELLER

Neovasc

Richmond, British Columbia, Canada
Category Company
Founded 2000
Sector Medical Products
Employees49
Revenue 3M USD (2021)
DESCRIPTION

Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Neovasc was founded in 2000 and is based in Richmond, British Columbia.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 2 of 2
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-01 Neovasc - XenoSure Rights

United States

Neovasc - XenoSure Rights is a bovine pericardium patch used primarily for carotid and vascular reconstructions.

Sell $5M
Mergr

Product

Company

Legal